BLIS Technologies (NZSE:BLT) Total Liabilities: NZ$1.93 Mil (As of Mar. 2026)


What is BLIS Technologies Total Liabilities?

BLIS Technologies NZSE:BLT +6.25% Total Liabilities is NZ$1.93 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

BLIS Technologies's Total Liabilities for the quarter that ended in Mar. 2026 was NZ$1.93 Mil.

BLIS Technologies's quarterly Total Liabilities increased from Mar. 2025 (NZ$1.97 Mil) to Sep. 2025 (NZ$2.00 Mil) but then declined from Sep. 2025 (NZ$2.00 Mil) to Mar. 2026 (NZ$1.93 Mil).

BLIS Technologies's annual Total Liabilities increased from Mar. 2024 (NZ$1.45 Mil) to Mar. 2025 (NZ$1.97 Mil) but then declined from Mar. 2025 (NZ$1.97 Mil) to Mar. 2026 (NZ$1.93 Mil).

BLIS Technologies Total Liabilities Historical Data

* Premium members only.

The historical data trend for BLIS Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BLIS Technologies Total Liabilities Chart

BLIS Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 1.97 1.45 1.97 1.93

BLIS Technologies Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.45 1.65 1.97 2.00 1.93

BLIS Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BLIS Technologies's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.671+(0.256+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.93

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=14.968-13.041
=1.93

BLIS Technologies's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.671+(0.256+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.93

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=14.968-13.041
=1.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NZ$1.93 Mil mean?
BLIS Technologies (NZSE:BLT) has a Total Liabilities of NZ$1.93 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BLIS Technologies and its competitors.
Is BLIS Technologies' Total Liabilities too high?
BLIS Technologies' current Total Liabilities is NZ$1.93 Mil.
How does BLIS Technologies' Total Liabilities compare to VRTX and REGN?
BLIS Technologies' Total Liabilities of NZ$1.93 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BLIS Technologies and its competitors. BLIS Technologies's current Total Liabilities is NZ$1.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 15% below its estimated fair value. The current Total Liabilities is NZ$1.93 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current Total Liabilities is NZ$1.93 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BLIS Technologies Business Description

Address 399 Moray Place, Dunedin Central, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.